Very early researchStudy completedNCT03547622What this trial is testingGalantamine and CBT4CBT Pilot to Prevent Relapse.Who this might be right forMethadone or Buprenorphine Detoxoxification Yale University 6
Post-approval studies (Phase 4)Study completedNCT00164242What this trial is testingTreatment of Tardive Dyskinesia With GalantamineWho this might be right forTardive Dyskinesia Caroff, Stanley N., M.D. 36
Not applicableStudy completedNCT00297414What this trial is testingAn Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineWho this might be right forMild Cognitive Impairment Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,083
Large-scale testing (Phase 3)Study completedNCT00261573What this trial is testingThe Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed DementiaWho this might be right forAlzheimer DiseaseVascular Dementia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 593
Early research (Phase 1)Study completedNCT01417429What this trial is testingGalantamine Effects on Nicotine Responses in SmokersWho this might be right forSmokingTobacco Withdrawal Yale University 12
Early research (Phase 1)Study completedNCT01039194What this trial is testingDrug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)Who this might be right forAlzheimer Disease Bristol-Myers Squibb 18
Post-approval studies (Phase 4)Study completedNCT00234637What this trial is testingRivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentWho this might be right forAlzheimer's Disease Novartis 204
Post-approval studies (Phase 4)Study completedNCT01478633What this trial is testingEvaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From DonepezilWho this might be right forAlzheimer's Disease Janssen Pharmaceutical K.K. 102
Post-approval studies (Phase 4)Study completedNCT01054976What this trial is testingThe Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Janssen Korea, Ltd., Korea 99
Post-approval studies (Phase 4)Study completedNCT00814658What this trial is testingThe Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of LifeWho this might be right forDementia Janssen-Cilag Farmaceutica Ltda. 22
Not applicableStudy completedNCT01009476What this trial is testingLong-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily RoutineWho this might be right forDementiaAlzheimer DiseaseDementia, Vascular Janssen-Cilag G.m.b.H 1,134
Large-scale testing (Phase 3)Study completedNCT00253227What this trial is testingThe Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 387
Large-scale testing (Phase 3)Study completedNCT00252603What this trial is testingGalantamine Versus Placebo in Childhood AutismWho this might be right forAutismChildhood Autism University of Medicine and Dentistry of New Jersey 20
Large-scale testing (Phase 3)Study completedNCT00645190What this trial is testingA Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Xian-Janssen Pharmaceutical Ltd. 215
Large-scale testing (Phase 3)Study completedNCT00253188What this trial is testingThe Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 653
Testing effectiveness (Phase 2)Study completedNCT00416169What this trial is testingA Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal DementiaWho this might be right forFrontotemporal DementiaPick Complex Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 41
Not applicableStudy completedNCT01194336What this trial is testingEvaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human PerformanceWho this might be right forBiomarkers, Pharmacological U.S. Army Medical Research and Development Command 84
Not applicableStudy completedNCT01129479What this trial is testingGalantamine Treatment for Nonfluent Aphasia in Stroke PatientsWho this might be right forAphasiaStroke University of North Carolina, Chapel Hill 8
Post-approval studies (Phase 4)UnknownNCT00219869What this trial is testingGalantamine in the Treatment of Post-Traumatic HeadacheWho this might be right forPost-Traumatic HeadacheHead Trauma,ClosedRetention Disorders,Cognitive Rapoport, Alan, M.D. 30
Large-scale testing (Phase 3)Ended earlyNCT00679627What this trial is testingGalantamine Used to Treat Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Janssen Research & Development, LLC 2,051